Keros Therapeutics Inc. (KROS)
NASDAQ · Healthcare
Keros Therapeutics Inc. Net Income 2019–2025
Keros Therapeutics Inc. annual/quarterly net income history and growth rate from 2019 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Keros Therapeutics Inc. net income for the quarter ending March 31, 2026 was -23.7 M, a 115.97% decrease year-over-year.
- Keros Therapeutics Inc. net income for the twelve months ending March 31, 2026 was 86.8 M, a 148.00% decrease year-over-year.
- Keros Therapeutics Inc. annual net income for 2025 was 87.0 M, a 146.44% decrease from 2024.
- Keros Therapeutics Inc. annual net income for 2024 was -187.4 M, a 22.46% increase from 2023.
- Keros Therapeutics Inc. annual net income for 2023 was -153.0 M, a 46.15% increase from 2022.
- Keros Therapeutics Inc. annual net income for 2022 was -104.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Keros Therapeutics Inc. Net Income — FAQ
Keros Therapeutics Inc. (KROS) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Keros Therapeutics Inc.'s net income?
Keros Therapeutics Inc. (KROS) reported net income of $87M for fiscal 2025.
Where can I see KROS's net income history?
The chart and table above show Keros Therapeutics Inc.'s net income by year and by quarter, including the growth rate.